NCT03563365

The Functional and Emotional Benefits of Replenix Power of Three With Resveratrol

A Randomized, Investigator Blinded, Single Site, Three Arm Clinical Study to Assess the Functional and Emotional Benefits of Replenix Power of Three Cream With Resveratrol , Replenix Power of Three Cream With Resveratrol With Adapalene and Benzoyl Peroxide Gel, 0.1%/2.5%, and Adapalene and Benzoyl Peroxide Gel, 0.1%/2.5%, Utilized to Treat Subjects With Facial Acne Vulgaris

• Status: Terminated
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 43 (actual)
• Sponsor: Yardley Dermatology Associates · Academic / Other
• Sex: All
• Age: 12 Years – 40 Years
• Healthy volunteers: Accepted

Summary

A Randomized, Investigator Blinded, Single Site, Three Arm Clinical Study to Assess the Functional and Emotional Benefits of Replenix Power of Three Cream with Resveratrol , Replenix Power of Three Cream with Resveratrol with Adapalene and Benzoyl Peroxide Gel, 0.1%/2.5%, and Adapalene and Benzoyl Peroxide Gel, 0.1%/2.5%, utilized to treat subjects with Facial Acne Vulgaris

Detailed description

Acne vulgaris is a common skin problem which can be challenging to treat. Enhancing the efficacy and tolerability of treatment regimens can enhance compliance and outcomes thereby potentially decreasing the morbidities associated with acne vulgaris. The present study is designed to assess the ability of Power of 3 with resveratrol to improve efficacy and tolerability of an existing combination acne medication.

Conditions

• Acne Vulgaris

Interventions

Type	Name	Description
OTHER	Replenix Power of 3 Cream with resveratrol	Cosmetic product containing Green Tea Polyphenols, Resveratrol, Caffeine USP, Bisabolol Cucumber extract, Chamomile extract, Rosemary extract, Squalane, Soy Phospholipids
DRUG	Adapalene and Benzoyl peroxide gel, 0.1%/2.5%	FDA approved topical agent for the treatment of acne

Timeline

• Start date: 2018-06-04
• Primary completion: 2021-03-02
• Completion: 2021-03-02
• First posted: 2018-06-20
• Last updated: 2021-04-23

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study